Inactive Instrument

LexaGene Holdings Inc. Toronto S.E.

Equities

LXG.H

CA52886L1031

Biotechnology & Medical Research

LexaGene Holdings Inc. Appoints Mr. Greg Dale as Vice President of Product Development and Manufacturing

January 25, 2018 at 09:02 pm IST

LexaGene Holdings Inc. announced the appointment of Mr. Greg Dale to the role of Vice President of Product Development and Manufacturing at LexaGene. Mr. Dale most recently served as Vice President, Product Development, Manufacturing and Quality at Emulate LLC.

Latest news about LexaGene Holdings Inc.

Chart LexaGene Holdings Inc.

Duration

Period

More charts

Company Profile

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
EXACT SCIENCES CORPORATION	-32.86%	868.21Cr
GUARDANT HEALTH, INC.	+25.06%	385.95Cr
IOVANCE BIOTHERAPEUTICS, INC.	+15.74%	242.89Cr
BGI GENOMICS CO., LTD.	-26.46%	183.93Cr
VERACYTE, INC.	-7.09%	172.7Cr
MARAVAI LIFESCIENCES HOLDINGS, INC.	+40.61%	116.36Cr
CAREDX, INC	+54.75%	84Cr
SEEGENE, INC.	-9.17%	70Cr
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-9.18%	59Cr

Bio Diagnostics & Testing